Emerging smart mobile health (or mHealth) technologies are changing the way patients track information related to diagnosed conditions. A new study examined the health and economic impacts of
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AMARYL® (am-a(r)-RILL) glimepiride (glim-epi-RIDE) Consumer Medicine Information (CMI) What is in this leaflet This leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KOMBIGLYZE® XR Saxagliptin/metformin hydrochloride modified release Consumer Medicine Information What is in this leaflet This
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APIDRA® (a-pid-ra) insulin glulisine (in-sue-lin glue-lee-seen) Consumer Medicine Information (CMI) What is in this leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REVLIMID® (lenalidomide) Consumer Medicine Information WARNING: Revlimid (lenalidomide) is structurally related to ‘thalidomide’, which is
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIABEX* XR contains the active ingredient metformin hydrochloride CONSUMER MEDICINE INFORMATION What is in this
A change in breakfast routine may provide benefits for the management of type 2 diabetes, according to a new study published in the Journal of Dairy Science. H.
It’s no secret that late night noshing is bad for our waistlines. But according to a new study, it’s also detrimental to our health. New research from the